Ubs Oconnor LLC Silence Therapeutics PLC Transaction History

Ubs Oconnor LLC

$1.46 Billion
Q3 2024

A detailed history of Ubs Oconnor LLC transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Ubs Oconnor LLC holds 85,701 shares of SLN stock, worth $456,786. This represents 0.11% of its overall portfolio holdings.

Number of Shares

85,701

Holding current value

$456,786

% of portfolio

0.11%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.53 - $21.74 $137,611 - $192,638	8,861 Added 11.53%	85,701 $1.56 Million
Q2 2024 Aug 14, 2024	BUY	$18.31 - $23.91 $84,537 - $110,392	4,617 Added 6.39%	76,840 $1.46 Million
Q1 2024 May 15, 2024	SELL	$17.39 - $26.25 $364,755 - $550,593	-20,975 Reduced 22.51%	72,223 $1.56 Million
Q4 2023 Feb 14, 2024	SELL	$6.7 - $17.67 $34,357 - $90,611	-5,128 Reduced 5.22%	93,198 $1.62 Million
Q2 2023 Aug 14, 2023	BUY	$4.61 - $7.44 $453,282 - $731,545	98,326 New	98,326 $541 Million
Q1 2023 May 15, 2023	BUY	$6.2 - $15.61 $39,971 - $100,637	6,447 Added 7.25%	95,383 $591,000
Q4 2022 Feb 14, 2023	BUY	$9.69 - $17.09 $90,117 - $158,937	9,300 Added 11.68%	88,936 $0
Q3 2022 Nov 14, 2022	BUY	$2.65 - $29.85 $134,673 - $1.52 Million	50,820 Added 176.36%	79,636 $786 Million
Q2 2022 Aug 12, 2022	BUY	$7.99 - $19.5 $230,239 - $561,912	28,816 New	28,816 $341,000

Others Institutions Holding SLN

# of Institutions

Shares Held

28.1M

Call Options Held

300

Put Options Held

Tcg Crossover Management, LLC Palo Alto, CA

3.03M
Shares

$16.2 Million
7.16% of portfolio
Siren, L.L.C. New York, NY

2.83M
Shares

$15.1 Million
2.57% of portfolio
Lombard Odier Asset Management (Usa) Corp New York, NY

2.66M
Shares

$14.2 Million
3.3% of portfolio
Redmile Group, LLC San Francisco, CA

1.9M
Shares

$10.1 Million
2.26% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

1.15M
Shares

$6.12 Million
1.12% of portfolio

View Full List

About Silence Therapeutics plc

Ticker SLN
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,888,400
Market Cap $191M
Description
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...

More about SLN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.

Account